Showing 801 - 820 results of 2,530 for search '"vaccines"', query time: 0.08s Refine Results
  1. 801

    Rabies in a Vaccinated 9-Month-Old German Shepherd Dog, Akure, 2010: A Case Report by A. M. Qasim, A. A. Obadua, P. A. Okewole, I. S. Tekki, O. S. Omoleye

    Published 2013-01-01
    “…Rabies has traditionally been associated with dogs more than any other animal, and in parts of the world where domestic animal control and vaccination programs are limited, dogs remain the most important reservoir of the disease. …”
    Get full text
    Article
  2. 802

    Predictors of COVID-19 vaccine acceptability among refugees and other migrant populations: A systematic scoping review. by Yasaman Yazdani, Poojitha Pai, Shahab Sayfi, Arash Mohammadi, Saber Perdes, Denise Spitzer, Gabriel E Fabreau, Kevin Pottie

    Published 2024-01-01
    “…Vaccine acceptability towards COVID-19 booster doses and various vaccine brands were not adequately studied.…”
    Get full text
    Article
  3. 803
  4. 804

    Simulating Immune Interference on the Effect of a Bivalent Glycoconjugate Vaccine against Haemophilus influenzae Serotypes “a” and “b” by Angjelina Konini, Mingsong Kang, Seyed M. Moghadas

    Published 2016-01-01
    “…We developed a stochastic simulation model of humoral immune response to investigate the antigenic challenge of a bivalent combined glycoconjugate vaccine and a bivalent unimolecular glycoconjugate vaccine. …”
    Get full text
    Article
  5. 805
  6. 806
  7. 807
  8. 808

    Naturally Occurring Hepatitis B Virus B-Cell and T-Cell Epitope Mutants in Hepatitis B Vaccinated Children by Yu-Min Lin, Guey-Mei Jow, Shu-Chi Mu, Bing-Fang Chen

    Published 2013-01-01
    “…To control hepatitis B virus (HBV) infection, a universal HBV vaccination program for infants was launched in Taiwan in 1984. …”
    Get full text
    Article
  9. 809
  10. 810
  11. 811
  12. 812
  13. 813
  14. 814
  15. 815

    Rubella Antibody Levels in School-Aged Children in Newfoundland: Implications for a Two-Dose Rubella Vaccination Strategy by Samuel Ratnam, Roy West, Veeresh Gadag, Brett Williams, Elizabeth Oates

    Published 1997-01-01
    “…OBJECTIVE: To determine the prevailing levels of rubella immunity among school-aged children who received a single dose of measles-mumps-rubella (MMR) vaccine at one year of age.…”
    Get full text
    Article
  16. 816

    Rapid Onset Severe Immune Thrombocytopenia following mRNA COVID-19 Vaccine in a Young Patient by Jorge Avila, Huseyin Berk Degirmenci, Pamela Contreras Chavez, Elisabeth M. Battinelli, Jorge Fleisher

    Published 2023-01-01
    “…The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people around the world. Vaccination against COVID-19 has been approved for the following three vaccines in the United States: Pfizer-BioNTech, Moderna, and Janssen. …”
    Get full text
    Article
  17. 817

    Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study by Tao Wang, Hongyan Li, Chaoqun Li, Zheheng Li

    Published 2022-07-01
    “…Objective By using health code blockchain, cities can maximise the use of personal information while maximising the protection of personal privacy in the monitoring and evaluation of the effectiveness of listed vaccines.Design This study constructs an urban COVID-19 listed vaccine effectiveness (VE) monitoring, evaluation and application system based on the health code blockchain. …”
    Get full text
    Article
  18. 818
  19. 819

    A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine by Imran Khan, K. M. Taufiqur Rahman, S. M. Saad Us Siraj, Mahbubul Karim, Abdul Muktadir, Arpan Maheshwari, Md Azizul Kabir, Zebun Nahar, Mohammad Mainul Ahasan

    Published 2016-01-01
    “…Molecular size distribution of meningococcal polysaccharide vaccine is a readily identifiable parameter that directly correlates with the immunogenicity. …”
    Get full text
    Article
  20. 820

    Design of Epitope-Based Peptide Vaccine against Pseudomonas aeruginosa Fructose Bisphosphate Aldolase Protein Using Immunoinformatics by Mustafa Elhag, Ruaa Mohamed Alaagib, Nagla Mohamed Ahmed, Mustafa Abubaker, Esraa Musa Haroun, Sahar Obi Abd Albagi, Mohammed A. Hassan

    Published 2020-01-01
    “…It usually affects immunocompromised individuals but can also infect immunocompetent individuals. There is no vaccine against it available till now. This study predicts an effective epitope-based vaccine against fructose bisphosphate aldolase (FBA) of Pseudomonas aeruginosa using immunoinformatics tools. …”
    Get full text
    Article